HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
Ananda Ayyappan Jaguva Vasudevan(Heinrich Heine University Düsseldorf), Günter Niegisch(German Cancer Research Center)
Cited by 19
Related Papers
Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
|Targeted Oncology|2016|57
Evaluation of <scp>HER2</scp> expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
|Cytometry Part B Clinical Cytometry|2020|16
Loop 1 of APOBEC3C regulates its antiviral activity against HIV-1
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
|Journal of Experimental & Clinical Cancer Research|2014|1